<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26062568</article-id>
      <article-id pub-id-type="pmc">4667673</article-id>
      <article-id pub-id-type="publisher-id">15-0180</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.15-0180</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Internal Medicine</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acquired Fanconi syndrome in a dog exposed to jerky treats in
Japan</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>IGASE</surname>
            <given-names>Masaya</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>BABA</surname>
            <given-names>Kenji</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>SHIMOKAWA MIYAMA</surname>
            <given-names>Takako</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>NOGUCHI</surname>
            <given-names>Shunsuke</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MIZUNO</surname>
            <given-names>Takuya</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>OKUDA</surname>
            <given-names>Masaru</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Laboratory of Veterinary Internal Medicine, Joint Faculty of
Veterinary Medicine, Yamaguchi University, Yamaguchi 753&#x2013;8515, Japan</aff>
        <aff id="aff2"><label>2)</label>Laboratory of Molecular Diagnostics and Therapeutics, Joint
Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi 753&#x2013;8515, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Baba, K., Laboratory of Veterinary
Internal Medicine, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677&#x2013;1
Yoshida, Yamaguchi 753&#x2013;8515, Japan. e-mail: <email xlink:href="kbaba@yamaguchi-u.ac.jp">kbaba@yamaguchi-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>6</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <volume>77</volume>
      <issue>11</issue>
      <fpage>1507</fpage>
      <lpage>1510</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>3</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>5</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 6-year-old spayed female Jack Russell Terrier presented with a 1-month
history of lethargy, anorexia, vomiting and weight loss. The dog was fed beef and chicken
jerky treats daily in addition to a commercial diet. Laboratory tests revealed azotemia,
hypokalemia, hyperchloremia, metabolic acidosis and glucosuria with normoglycemia. Urine
amino acid analysis showed significant amino acid loss into the urine. Thus, Fanconi
syndrome was diagnosed, and based on the case history and extensive diagnostic testing,
excessive consumption of jerky treats was strongly suspected as the cause. Glucosuria
resolved 7 days after the withdrawal of jerky treats and fluid therapy. Aminoaciduria was
substantially, but not completely, improved 3 months after diagnosis. Mild azotemia
remained, suggesting chronic renal disease. To the best of our knowledge, this is the
first reported case of Fanconi syndrome following the consumption of jerky treats in
Japan.</p>
      </abstract>
      <kwd-group>
        <kwd>aminoaciduria</kwd>
        <kwd>canine</kwd>
        <kwd>Fanconi syndrome</kwd>
        <kwd>Japan</kwd>
        <kwd>jerky treat</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Fanconi syndrome is characterized by impaired reabsorptive function of the proximal renal
tubule, resulting in excessive loss of water, glucose, amino acids, uric acid, phosphate,
bicarbonate and other electrolytes [<xref rid="r2" ref-type="bibr">2</xref>]. Inherited
Fanconi syndrome has been well documented in Basenji dogs [<xref rid="r16" ref-type="bibr">16</xref>], whereas acquired Fanconi syndrome is rarely recognized in dogs. Previously
reported cases of acquired Fanconi syndrome occurred in dogs with hepatic copper toxicosis,
leptospirosis, primary hypoparathyroidism and hereditary renal disease [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>]. Acquired Fanconi syndrome has also been associated with exposure to ethylene
glycol, streptozotocin, antibiotics and more recently, chicken jerky treats [<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r14" ref-type="bibr">14</xref>, <xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. Since 2007, the Food and Drug Administration (FDA) has
warned of a potential association between illness and consumption of chicken jerky treats
[<xref rid="r6" ref-type="bibr">6</xref>]. Nonspecific signs have been noted, including
lethargy, anorexia, vomiting, diarrhea and polyuria/polydipsia. Laboratory testing may reveal
renal failure, glucosuria with normoglycemia, metabolic acidosis and generalized
aminoaciduria, indicating Fanconi syndrome. Cases of Fanconi syndrome associated with chicken
jerky treats have been documented in North America, Australia and Europe, but not in Asia
[<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r12" ref-type="bibr">12</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. Notably, in
almost all cases, dogs have consumed chicken jerky treats with ingredients from China. Given
the global distribution of pet food products, the increase in the number of cases is worrisome
worldwide. The present report describes the clinical features and treatment outcomes of a dog
in Japan with Fanconi syndrome after consuming jerky treats, some of which contained
ingredients from China.</p>
    <p>A 6-year-old spayed female Jack Russell Terrier, weighing 5.4 kg, was referred to Yamaguchi
University Animal Medical Center for evaluation of a 1-month history of lethargy, anorexia,
vomiting and weight loss. These clinical signs were not resolved after general management at
the local animal hospital. Two days before the initial visit, azotemia, hypokalemia and
glucosuria were measured at the local animal hospital. The dog was fed different beef and
chicken jerky treats daily, some of which contained ingredients from China, in addition to a
commercial diet. Once anorexia was observed, much of her diet had been jerky treats for 1
month, as a result of her dietary preferences.</p>
    <p>At the time of initial presentation, a blood test revealed normal complete blood cell count
(CBC) and increased blood urea nitrogen (BUN) (119.8 mg/d<italic>l</italic>; reference range,
9.2&#x2013;29.2 mg/d<italic>l</italic>) and creatinine (2.4 mg/d<italic>l</italic>; reference range,
0.4&#x2013;1.4 mg/d<italic>l</italic>). In addition, hypokalemia (2.1 mEq/<italic>l</italic>;
reference range, 3.8&#x2013;5.0 mEq/<italic>l</italic>) and hyperchloremia (122
mEq/<italic>l</italic>; reference range, 102&#x2013;117 mEq/<italic>l</italic>) were also revealed.
Blood glucose was within the normal range (95 mg/d<italic>l</italic>; reference range, 75&#x2013;128
mg/d<italic>l</italic>). Urinalysis showed a specific gravity of 1.038, a pH of 6.0,
moderate glucosuria (250 mg/d<italic>l</italic>, determined by dipstick) and trace proteinuria
(30 mg/d<italic>l</italic>, determined by dipstick). Urine protein/creatinine ratio was 0.42
(reference range, &lt;0.5). Urine sediment identified epithelial and granular casts without
hematuria, pyuria or bacteriuria. Venous blood gas analysis showed metabolic acidosis with a
pH of 7.292 (reference range, 7.35&#x2013;7.45), a venous CO<sub>2</sub> pressure (PvCO<sub>2</sub>)
of 32.7 mm Hg (reference range, 40&#x2013;50 mm Hg), a bicarbonate concentration of 15.4
mmol/<italic>l</italic> (reference range, 20&#x2013;24 mmol/<italic>l</italic>) and a base excess
(BE) of &#x2212;9.9 mmol/<italic>l </italic>(reference range, &#x2212;4 to +4 mmol/<italic>l</italic>). No
significant abnormalities were observed on radiography and abdominal ultrasonography.</p>
    <p>Because of the suspicion of Fanconi syndrome, a spot urine sample was submitted for amino
acids and derivatives analysis by high performance liquid chromatography (Bio Medical
Laboratories, Saitama, Japan). To correct for the influence of urinary concentration or
dilution in spot urine samples, the urinary excretions of amino acids and derivatives were
adjusted for the urinary creatinine concentration (<italic>&#xB5;</italic>mol/g of creatinine) as
described previously [<xref rid="r22" ref-type="bibr">22</xref>]. Because reference values for
the urine amino acids and derivatives profile had not been established, the measured value was
compared with that of three healthy dogs. Increased excretion of most amino acids was found,
but not all amino acids and derivatives were lost equally (<xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Urine amino acids and derivatives profile (mmol/g&#x387;cre)*</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="center" rowspan="1" colspan="1">Substance</th><th valign="middle" align="center" rowspan="1" colspan="1">Initial visit</th><th valign="middle" align="center" rowspan="1" colspan="1">Three months after</th><th valign="middle" align="center" rowspan="1" colspan="1">Reference value**</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Taurine</td><td align="center" valign="middle" rowspan="1" colspan="1">173.4</td><td align="center" valign="middle" rowspan="1" colspan="1">1,988.9</td><td align="center" valign="middle" rowspan="1" colspan="1">7,049.4 &#xB1; 3,439.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Phosphorthanol-amine</td><td align="center" valign="middle" rowspan="1" colspan="1">70.1</td><td align="center" valign="middle" rowspan="1" colspan="1">201.2</td><td align="center" valign="middle" rowspan="1" colspan="1">60.9 &#xB1; 48.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Aspartic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4</td><td align="center" valign="middle" rowspan="1" colspan="1">14.1</td><td align="center" valign="middle" rowspan="1" colspan="1">5.9 &#xB1; 3.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hydroxyproline</td><td align="center" valign="middle" rowspan="1" colspan="1">211.2</td><td align="center" valign="middle" rowspan="1" colspan="1">153.4</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Threonine</td><td align="center" valign="middle" rowspan="1" colspan="1">4,587.4</td><td align="center" valign="middle" rowspan="1" colspan="1">659.2</td><td align="center" valign="middle" rowspan="1" colspan="1">79.9 &#xB1; 88.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Serine</td><td align="center" valign="middle" rowspan="1" colspan="1">1,531.5</td><td align="center" valign="middle" rowspan="1" colspan="1">267.7</td><td align="center" valign="middle" rowspan="1" colspan="1">126.6 &#xB1; 30.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Asparagine</td><td align="center" valign="middle" rowspan="1" colspan="1">851.9</td><td align="center" valign="middle" rowspan="1" colspan="1">98.3</td><td align="center" valign="middle" rowspan="1" colspan="1">29.9 &#xB1; 25.8</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glutamic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">122.9</td><td align="center" valign="middle" rowspan="1" colspan="1">44.2</td><td align="center" valign="middle" rowspan="1" colspan="1">25.9 &#xB1; 12.9</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glutamine</td><td align="center" valign="middle" rowspan="1" colspan="1">11,874.9</td><td align="center" valign="middle" rowspan="1" colspan="1">635.7</td><td align="center" valign="middle" rowspan="1" colspan="1">98.7 &#xB1; 47.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sarcosine</td><td align="center" valign="middle" rowspan="1" colspan="1">28.2</td><td align="center" valign="middle" rowspan="1" colspan="1">306.0</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x3B1;-Aminoadipic acid</td><td align="center" valign="middle" rowspan="1" colspan="1">166.3</td><td align="center" valign="middle" rowspan="1" colspan="1">96.6</td><td align="center" valign="middle" rowspan="1" colspan="1">32.0 &#xB1; 19.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Proline</td><td align="center" valign="middle" rowspan="1" colspan="1">173.4</td><td align="center" valign="middle" rowspan="1" colspan="1">203.9</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glycine</td><td align="center" valign="middle" rowspan="1" colspan="1">3,544.5</td><td align="center" valign="middle" rowspan="1" colspan="1">396.4</td><td align="center" valign="middle" rowspan="1" colspan="1">68.7 &#xB1; 31.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Alanine</td><td align="center" valign="middle" rowspan="1" colspan="1">6,077.1</td><td align="center" valign="middle" rowspan="1" colspan="1">583.9</td><td align="center" valign="middle" rowspan="1" colspan="1">192.3 &#xB1; 103.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Citrulline</td><td align="center" valign="middle" rowspan="1" colspan="1">1,956.7</td><td align="center" valign="middle" rowspan="1" colspan="1">503.5</td><td align="center" valign="middle" rowspan="1" colspan="1">27.1 &#xB1; 12.9</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x3B1;-Amino-n-butyric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">250.2</td><td align="center" valign="middle" rowspan="1" colspan="1">9.1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3 &#xB1; 1.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Valine</td><td align="center" valign="middle" rowspan="1" colspan="1">373.9</td><td align="center" valign="middle" rowspan="1" colspan="1">90.1</td><td align="center" valign="middle" rowspan="1" colspan="1">21.3 &#xB1; 5.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cystine</td><td align="center" valign="middle" rowspan="1" colspan="1">633.6</td><td align="center" valign="middle" rowspan="1" colspan="1">114.4</td><td align="center" valign="middle" rowspan="1" colspan="1">27.6 &#xB1; 9.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Methionine</td><td align="center" valign="middle" rowspan="1" colspan="1">57.9</td><td align="center" valign="middle" rowspan="1" colspan="1">244.6</td><td align="center" valign="middle" rowspan="1" colspan="1">45.3 &#xB1; 56.9</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cystathionine</td><td align="center" valign="middle" rowspan="1" colspan="1">251.9</td><td align="center" valign="middle" rowspan="1" colspan="1">356.8</td><td align="center" valign="middle" rowspan="1" colspan="1">11.2 &#xB1; 10.0</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Isoleucine</td><td align="center" valign="middle" rowspan="1" colspan="1">123.4</td><td align="center" valign="middle" rowspan="1" colspan="1">2.4</td><td align="center" valign="middle" rowspan="1" colspan="1">5.5 &#xB1; 2.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Leucine</td><td align="center" valign="middle" rowspan="1" colspan="1">185.4</td><td align="center" valign="middle" rowspan="1" colspan="1">12.7</td><td align="center" valign="middle" rowspan="1" colspan="1">39.4 &#xB1; 18.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tyrosine</td><td align="center" valign="middle" rowspan="1" colspan="1">552.1</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Phenylalanine</td><td align="center" valign="middle" rowspan="1" colspan="1">247.4</td><td align="center" valign="middle" rowspan="1" colspan="1">5.3</td><td align="center" valign="middle" rowspan="1" colspan="1">4.3 &#xB1; 1.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x3B2;-Alanine</td><td align="center" valign="middle" rowspan="1" colspan="1">25.4</td><td align="center" valign="middle" rowspan="1" colspan="1">60.8</td><td align="center" valign="middle" rowspan="1" colspan="1">72.6 &#xB1; 44.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x3B2;-Amino-iso-butyric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">45.3</td><td align="center" valign="middle" rowspan="1" colspan="1">136.8</td><td align="center" valign="middle" rowspan="1" colspan="1">31.8 &#xB1; 16.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Homocystine</td><td align="center" valign="middle" rowspan="1" colspan="1">40.6</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x3B3;-Amino-n-butyric acid</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ethanolamine</td><td align="center" valign="middle" rowspan="1" colspan="1">149.1</td><td align="center" valign="middle" rowspan="1" colspan="1">150.7</td><td align="center" valign="middle" rowspan="1" colspan="1">91.8 &#xB1; 10.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hydroxylysin</td><td align="center" valign="middle" rowspan="1" colspan="1">6.7</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ornithine</td><td align="center" valign="middle" rowspan="1" colspan="1">108.1</td><td align="center" valign="middle" rowspan="1" colspan="1">26.0</td><td align="center" valign="middle" rowspan="1" colspan="1">12.1 &#xB1; 7.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tryptophan</td><td align="center" valign="middle" rowspan="1" colspan="1">316.1</td><td align="center" valign="middle" rowspan="1" colspan="1">11.5</td><td align="center" valign="middle" rowspan="1" colspan="1">5.9 &#xB1; 5.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lysine</td><td align="center" valign="middle" rowspan="1" colspan="1">423.8</td><td align="center" valign="middle" rowspan="1" colspan="1">51.5</td><td align="center" valign="middle" rowspan="1" colspan="1">44.0 &#xB1; 18.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1-Methyl-histidine</td><td align="center" valign="middle" rowspan="1" colspan="1">516.7</td><td align="center" valign="middle" rowspan="1" colspan="1">522.3</td><td align="center" valign="middle" rowspan="1" colspan="1">688.1 &#xB1; 493.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Histidine</td><td align="center" valign="middle" rowspan="1" colspan="1">1,567.3</td><td align="center" valign="middle" rowspan="1" colspan="1">118.8</td><td align="center" valign="middle" rowspan="1" colspan="1">19.1 &#xB1; 2.8</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3-Methyl-histidine</td><td align="center" valign="middle" rowspan="1" colspan="1">384.8</td><td align="center" valign="middle" rowspan="1" colspan="1">265.8</td><td align="center" valign="middle" rowspan="1" colspan="1">177.1 &#xB1; 40.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Anserine</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Carnosine</td><td align="center" valign="middle" rowspan="1" colspan="1">10.1</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" rowspan="1" colspan="1">ND</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Arginine</td><td align="center" valign="middle" rowspan="1" colspan="1">97.7</td><td align="center" valign="middle" rowspan="1" colspan="1">54.2</td><td align="center" valign="middle" rowspan="1" colspan="1">17.4 &#xB1; 6.9</td></tr></tbody></table><table-wrap-foot><p>*The concentrations of amino acids and derivatives (mmol/<italic>l</italic>) were
calibrated by the concentration of creatinine (g/<italic>l</italic>). **The reference
values were calculated as average &#xB1; 2 standard deviation of the concentrations of amino
acids and derivatives in 3 healthy dogs. ND: Not detected</p></table-wrap-foot></table-wrap>). Given glucosuria in the absence of hyperglycemia, metabolic acidosis and
generalized aminoaciduria, a diagnosis of Fanconi syndrome was established.</p>
    <p>The possible cause of Fanconi syndrome was carefully explored. Medications associated with
acquired Fanconi syndrome, such as antibiotics, nonsteroidal anti-inflammatory drugs and
cyclosporine, had not been administered prior to onset of clinical signs. It was highly
unlikely that the dog was exposed to environmental toxins, such as cadmium, lead and mercury,
according to the dog&#x2019;s history and life circumstances. Hepatic copper toxicosis and primary
hypoparathyroidism were excluded by the absence of hepatic insufficiency and hypocalcemia,
respectively. Titers for <italic>Leptospira interrogans</italic>(serovars canicola,
icterohaemorrhagiae and hebdomadis) were examined and eventually reported as negative. In
humans, Fanconi syndrome may result from tubular injury related to urinary excretion of
abnormal proteins, such as multiple myeloma and amyloidosis [<xref rid="r13" ref-type="bibr">13</xref>, <xref rid="r17" ref-type="bibr">17</xref>]. In the dog, multiple myeloma was
excluded by the absence of hyperproteinemia and osteolytic bone lesions. Amyloidosis was also
excluded by the absence of proteinuria, although a renal biopsy was not performed. Urinary
tract infection and pyelonephritis could not be definitively excluded, because a urine culture
was not performed; however, they were highly unlikely as the cause of Fanconi syndrome in the
dog, because pyuria and bacteriuria were not observed in the urine sediment. On the basis of
the case history and findings, the excess consumption of jerky treats was strongly suspected
as the cause of Fanconi syndrome.</p>
    <p>The dog was hospitalized and treated with acetated Ringer&#x2019;s solution with 40
mEq/<italic>l</italic> of potassium chloride. The dog was also treated with potassium sodium
hydrogen citrate (Uralyte<sup>&#xAE;</sup>, 231.5 mg of potassium citrate and 195 mg of sodium
hydrogen citrate, PO, BID), famotidine (0.5 mg/kg, IV, SID) and metronidazole (11 mg/kg, PO,
BID). The jerky treats were immediately withdrawn. On day 2 of hospitalization, BUN (78.5
mg/d<italic>l</italic>), creatinine (2.1 mg/d<italic>l</italic>), potassium (3.0
mEq/<italic>l</italic>) and chloride (122 mEq/<italic>l</italic>) levels were measured.
Metabolic acidosis was resolved (pH, 7.402; PvCO<sub>2</sub>, 36.9 mm Hg; bicarbonate, 22.5
mmol/<italic>l</italic>; and BE, &#x2212;1.9). Glucosuria was still present, but it mildly improved
(100 mg/d<italic>l</italic>, determined by dipstick). On day 3 of hospitalization, BUN (49.2
mg/d<italic>l</italic>), creatinine (1.9 mg/d<italic>l</italic>), potassium (2.9
mEq/<italic>l</italic>) and chloride (119 mEq/<italic>l</italic>) levels were measured
again. Metabolic acidosis continued to improve (pH, 7.393; PvCO<sub>2</sub>, 36.9 mm Hg;
bicarbonate, 22.0 mmol/<italic>l</italic>; and BE, &#x2212;2.5). Glucosuria was still present (100
mg/d<italic>l</italic>, determined by dipstick). On day 4 of hospitalization, the dog was
discharged, although her appetite had not improved. After discharge, the dog was treated with
the same regimen everyday at the local animal hospital. Three days after discharge, partial
improvement in her appetite was observed, and glucosuria was completely resolved. Because mild
azotemia remained, daily subcutaneous fluid therapy was continued. Three months after the
initial administration, no clinical signs were observed. The CBC was normal. However, mild
azotemia remained (BUN, 36.2 mg/d<italic>l</italic> and creatinine, 2.0
mg/d<italic>l</italic>), resulting in chronic kidney disease. The urinalysis showed complete
resolution of glucosuria. The urine amino acid analysis revealed that aminoaciduria was
substantially, but not completely, improved (<xref rid="tbl_001" ref-type="table">Table
1</xref>).</p>
    <p>Renal tubular acidosis (RTA) has been classified into distal RTA and proximal RTA based on
the anatomic location of tubular defect. Proximal RTA caused by impaired bicarbonate
reabsorption in the proximal renal tubule is a characteristic of Fanconi syndrome. Proximal
RTA typically causes hyperchloremic metabolic acidosis secondary to loss of bicarbonate,
hypokalemia due to promoted potassium excretion and acidic urine due to secretion of hydrogen
ions in the distal tubule. In the dog, the presence of hyperchloremic metabolic acidosis,
hypokalemia and acidic urine supported a diagnosis of proximal RTA. In conjunction with
proximal RTA, glucosuria without hyperglycemia and generalized aminoaciduria indicated a
generalized proximal renal tubular defect and confirmed the diagnosis of Fanconi syndrome.</p>
    <p>In the dog, the urinary loss of most amino acids was increased, but not all amino acids, and
derivatives were lost equally. Dogs with Fanconi syndrome typically have generalized
aminoaciduria including acidic, basic and neutral amino acids. In a previous report, a dog
with idiopathic Fanconi syndrome appeared to have increased excretion of amino acids with
basic side chains, whereas those with acidic side chains (i.e., aspartic acid and glutamic
acid) were less affected [<xref rid="r18" ref-type="bibr">18</xref>]. Interestingly, the dog
in this report had no urinary loss of aspartic acid, and excretion of glutamic acid was
elevated but not excessive. The differences may be related to defects in specific amino acid
transport mechanisms depending on the underlying causes. In addition, the urinary
concentration of taurine was reduced in the dog compared with that in normal dogs. A previous
report indicated that urinary excretion level of taurine could be affected by the quantity of
taurine and other components contained in ingested food [<xref rid="r21" ref-type="bibr">21</xref>]. The differences of urinary taurine concentration between the affected dog and
control dogs may be related to the consumed diets.</p>
    <p>The dog was fed different beef and chicken jerky treats daily, some of which contained
ingredients from China. After symptom onset, much of her diet had been jerky treats for 1
month. After diagnosis of Fanconi syndrome, on the basis of the case history and extensive
diagnosis testing, jerky treats were strongly suspected as the cause of Fanconi syndrome.
Indeed, 1 week after their withdrawal, glucosuria was completely resolved, and the dog&#x2019;s
appetite was gradually improved. After 3 months, there were no clinical signs, and
aminoaciduria was substantially improved. According to the clinical course, jerky treats were
eventually concluded to be the cause of Fanconi syndrome in the dog. Unfortunately, the
specific product could not be identified as the causal component, because the dog had been fed
several kinds of jerky treats. However, all jerky treats consumed by the dog could be commonly
purchased in Japan. In fact, it should be noted that toxicosis associated with jerky treats
can unsurprisingly occur in Japan.</p>
    <p>The common clinical features of Fanconi syndrome associated with chicken jerky treats have
been documented in previous reports [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. The clinical signs observed in this case, including
lethargy, anorexia, vomiting and weight loss, were similar to those observed in previous
cases. Small breeds (&lt;10 kg) appear to be mostly affected, accounting for 88%. The dog in
this report also weighed &lt;10 kg (5.4 kg). This is likely because of the proportionally
larger quantity of jerky treats consumed in small breeds. The period of time that jerky treats
were fed prior to the onset of clinical signs ranged from 0.3 to 78 weeks in previous cases.
Although the precise period of time that jerky treats were fed in this case was unknown,
severe azotemia was documented 1 month after the onset of lethargy and anorexia. In this
period, renal function appeared to be severely damaged, because of the increase in the
quantity of jerky treats consumed. The dog continued to have mild azotemia 3 months after
treatment, suggesting irreversible renal dysfunction. Indeed, despite the withdrawal of jerky
treats, permanent kidney damage appears to occur in some cases, resulting in chronic renal
disease [<xref rid="r20" ref-type="bibr">20</xref>]. A histopathological examination of the
kidney in acute and chronic phases may be helpful to reveal the mechanism underlying renal
damage.</p>
    <p>At the time of writing, despite extensive investigations by the FDA, the specific causative
substance has not been determined, and unfortunately, it could not be investigated in this
report. In humans, degraded tetracyclines have been implicated as a cause of acquired Fanconi
syndrome [<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r15" ref-type="bibr">15</xref>].
Recently, 6 illegal antibiotics, including trimethoprim, tilmicosin, enrofloxacin,
sulfaclozine and sulfamethoxazole, have been detected in chicken jerky products for dogs
[<xref rid="r19" ref-type="bibr">19</xref>]. However, there is no evidence indicating the
relation between these antibiotics and the illness. Further investigations of the causative
substance, including contaminating antibiotics and others, are warranted.</p>
    <p>In conclusion, this is the first reported case of Fanconi syndrome following the consumption
of jerky treats in Japan. For diagnosis of this disease, it is important to take a careful
dietary history and perform urinalysis in dogs with nonspecific signs. If an association
between the illness and jerky treat consumption is suspected, such treats should be
immediately withdrawn, although irreversible renal dysfunction may remain. Veterinary
clinicians should be aware of the toxicosis associated with jerky treats and report cases to
regulatory authorities to prevent outbreaks.</p>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Appleman</surname><given-names>E. H.</given-names></name><name><surname>Cianciolo</surname><given-names>R.</given-names></name><name><surname>Mosenco</surname><given-names>A. S.</given-names></name><name><surname>Bounds</surname><given-names>M. E.</given-names></name><name><surname>AI-Ghazlat</surname><given-names>S.</given-names></name></person-group><year>2008</year>. <article-title>Transient acquired Fanconi syndrome
associated with copper storage hepatopathy in 3 dogs</article-title>. <source><italic>J.
Vet. Intern. Med.</italic></source><volume>22</volume>:
<fpage>1038</fpage>&#x2013;<lpage>1042</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1939-1676.2008.0140.x</pub-id><pub-id pub-id-type="pmid">18647161</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Bov&#xE9;e</surname><given-names>K. C.</given-names></name><name><surname>Joyce</surname><given-names>T.</given-names></name><name><surname>Blazer-Yost</surname><given-names>B.</given-names></name><name><surname>Goldschmidt</surname><given-names>M. S.</given-names></name><name><surname>Segal</surname><given-names>S.</given-names></name></person-group><year>1979</year>. <article-title>Characterization of renal defects in dogs
with a syndrome similar to the Fanconi syndrome in man</article-title>.
<source><italic>J. Am. Vet. Med. Assoc.</italic></source><volume>174</volume>:
<fpage>1094</fpage>&#x2013;<lpage>1099</lpage>. <pub-id pub-id-type="pmid">438041</pub-id></mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Brown</surname><given-names>S. A.</given-names></name><name><surname>Rakich</surname><given-names>P. M.</given-names></name><name><surname>Barsanti</surname><given-names>J. A.</given-names></name><name><surname>Finco</surname><given-names>D. R.</given-names></name><name><surname>Kickbush</surname><given-names>C.</given-names></name></person-group><year>1986</year>
<article-title>Fanconi syndrome and acute renal failure
associated with gentamicin therapy in a dog</article-title>. <source><italic>J. Am.
Anim. Hosp. Assoc.</italic></source><volume>22</volume>:
<fpage>635</fpage>&#x2013;<lpage>640</lpage>.</mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Carmichael</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Giger</surname><given-names>U.</given-names></name></person-group><year>2014</year>. <article-title>Fanconi syndrome in dog in the
UK</article-title>. <source><italic>Vet. Rec.</italic></source><volume>174</volume>:
<fpage>357</fpage>&#x2013;<lpage>358</lpage>. doi: <pub-id pub-id-type="doi">10.1136/vr.g2554</pub-id><pub-id pub-id-type="pmid">24700011</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Cleveland</surname><given-names>W. W.</given-names></name><name><surname>Adams</surname><given-names>W. C.</given-names></name><name><surname>Mann</surname><given-names>J. B.</given-names></name><name><surname>Nyhan</surname><given-names>W. L.</given-names></name></person-group><year>1965</year>. <article-title>Acquired Fanconi syndrome following
degraded tetracycline</article-title>. <source><italic>J.
Pediatr.</italic></source><volume>66</volume>: <fpage>333</fpage>&#x2013;<lpage>342</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/S0022-3476(65)80190-1</pub-id><pub-id pub-id-type="pmid">14258922</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="eref">FDA. <year>2015</year>
Questions and answers regarding jerky pet treats. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm295445.htm">http://www.fda.gov/AnimalVeterinary/SafetyHealth/ProductSafetyInformation/ucm295445.htm</ext-link>.</mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Finco</surname><given-names>D. R.</given-names></name></person-group><year>1976</year>. <article-title>Familial renal disease in Norwegian
Elkhound dogs: physiologic and biochemical examinations</article-title>.
<source><italic>Am. J. Vet. Res.</italic></source><volume>37</volume>:
<fpage>87</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="pmid">942838</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Freeman</surname><given-names>L. M.</given-names></name><name><surname>Breitschwerdt</surname><given-names>E. B.</given-names></name><name><surname>Keene</surname><given-names>B. W.</given-names></name><name><surname>Hansen</surname><given-names>B.</given-names></name></person-group><year>1994</year>. <article-title>Fanconi&#x2019;s syndrome in a dog with primary
hypoparathyroidism</article-title>. <source><italic>J. Vet. Intern.
Med.</italic></source><volume>8</volume>: <fpage>349</fpage>&#x2013;<lpage>354</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1939-1676.1994.tb03249.x</pub-id><pub-id pub-id-type="pmid">7837112</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Green</surname><given-names>C. E.</given-names></name><name><surname>Sykes</surname><given-names>J. E.</given-names></name><name><surname>Brown</surname><given-names>C. A.</given-names></name><name><surname>Hartman</surname><given-names>K.</given-names></name></person-group><year>2006</year> Leptospirosis. pp. 402&#x2013;417. <italic>In</italic>:
Infectious Diseases of the Dog and Cat, 3rd ed. (Green, C. E. ed.), Elsevier, St.
Louis.</mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Hill</surname><given-names>T. L.</given-names></name><name><surname>Breitschwerdt</surname><given-names>E. B.</given-names></name><name><surname>Cecere</surname><given-names>T.</given-names></name><name><surname>Vaden</surname><given-names>S.</given-names></name></person-group><year>2008</year>. <article-title>Concurrent hepatic copper toxicosis and
Fanconi&#x2019;s syndrome in a dog</article-title>. <source><italic>J. Vet. Intern.
Med.</italic></source><volume>22</volume>: <fpage>219</fpage>&#x2013;<lpage>222</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1939-1676.2007.0040.x</pub-id><pub-id pub-id-type="pmid">18289313</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Hooper</surname><given-names>A. N.</given-names></name><name><surname>Roberts</surname><given-names>B. K.</given-names></name></person-group><year>2011</year>. <article-title>Fanconi syndrome in four non-basenji dogs
exposed to chicken jerky treats</article-title>. <source><italic>J. Am. Anim. Hosp.
Assoc.</italic></source><volume>47</volume>: <fpage>e178</fpage>&#x2013;<lpage>e187</lpage>.
doi: <pub-id pub-id-type="doi">10.5326/JAAHA-MS-5602</pub-id><pub-id pub-id-type="pmid">22058368</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Major</surname><given-names>A.</given-names></name><name><surname>Schweighauser</surname><given-names>A.</given-names></name><name><surname>Hinden</surname><given-names>S. E.</given-names></name><name><surname>Francey</surname><given-names>T.</given-names></name></person-group><year>2014</year>. <article-title>Transient Fanconi syndrome with severe
polyuria and polydipsia in a 4-year old Shih Tzu fed chicken jerky
treats</article-title>. <source><italic>Schweiz. Arch.
Tierheilkd.</italic></source><volume>156</volume>:
<fpage>593</fpage>&#x2013;<lpage>598</lpage>. doi: <pub-id pub-id-type="doi">10.1024/0036-7281/a000655</pub-id><pub-id pub-id-type="pmid">25497565</pub-id></mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Maldonado</surname><given-names>J. E.</given-names></name><name><surname>Velosa</surname><given-names>J. A.</given-names></name><name><surname>Kyle</surname><given-names>R. A.</given-names></name><name><surname>Wagoner</surname><given-names>R. D.</given-names></name><name><surname>Holley</surname><given-names>K. E.</given-names></name><name><surname>Salassa</surname><given-names>R. M.</given-names></name></person-group><year>1975</year>. <article-title>Fanconi syndrome in adults. A
manifestation of a latent form of myeloma</article-title>. <source><italic>Am. J.
Med.</italic></source><volume>58</volume>: <fpage>354</fpage>&#x2013;<lpage>364</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/0002-9343(75)90601-4</pub-id><pub-id pub-id-type="pmid">163583</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Meyer</surname><given-names>D. J.</given-names></name></person-group><year>1977</year>. <article-title>Temporary remission of hypoglycemia in a
dog with an insulinoma after treatment with streptozotocin</article-title>.
<source><italic>Am. J. Vet. Res.</italic></source><volume>38</volume>:
<fpage>1201</fpage>&#x2013;<lpage>1204</lpage>. <pub-id pub-id-type="pmid">199092</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Montoliu</surname><given-names>J.</given-names></name><name><surname>Carrera</surname><given-names>M.</given-names></name><name><surname>Darnell</surname><given-names>A.</given-names></name><name><surname>Revert</surname><given-names>L.</given-names></name></person-group><year>1981</year>. <article-title>Lactic acidosis and Fanconi&#x2019;s syndrome
due to degraded tetracycline</article-title>. <source><italic>Br. Med. J. (Clin. Res.
Ed.)</italic></source><volume>283</volume>: <fpage>1576</fpage>&#x2013;<lpage>1577</lpage>.
doi: <pub-id pub-id-type="doi">10.1136/bmj.283.6306.1576-a</pub-id><pub-id pub-id-type="pmid">6796174</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Noonan</surname><given-names>C. H.</given-names></name><name><surname>Kay</surname><given-names>J. M.</given-names></name></person-group><year>1990</year>. <article-title>Prevalence and geographic distribution of
Fanconi syndrome in Basenjis in the United States</article-title>. <source><italic>J.
Am. Vet. Med. Assoc.</italic></source><volume>197</volume>:
<fpage>345</fpage>&#x2013;<lpage>349</lpage>. <pub-id pub-id-type="pmid">2391269</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rikitake</surname><given-names>O.</given-names></name><name><surname>Sakemi</surname><given-names>T.</given-names></name><name><surname>Yoshikawa</surname><given-names>Y.</given-names></name><name><surname>Nagano</surname><given-names>Y.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name></person-group><year>1989</year>. <article-title>Adult Fanconi syndrome in primary
amyloidosis with lambda light-chain proteinuria</article-title>. <source><italic>Jpn. J.
Med.</italic></source><volume>28</volume>: <fpage>523</fpage>&#x2013;<lpage>526</lpage>. doi:
<pub-id pub-id-type="doi">10.2169/internalmedicine1962.28.523</pub-id><pub-id pub-id-type="pmid">2509772</pub-id></mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Settles</surname><given-names>E. L.</given-names></name><name><surname>Schmidt</surname><given-names>D.</given-names></name></person-group><year>1994</year>. <article-title>Fanconi syndrome in a Labrador
retriever</article-title>. <source><italic>J. Vet. Intern.
Med.</italic></source><volume>8</volume>: <fpage>390</fpage>&#x2013;<lpage>393</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/j.1939-1676.1994.tb03256.x</pub-id><pub-id pub-id-type="pmid">7884724</pub-id></mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Sheridan</surname><given-names>R.</given-names></name><name><surname>Mirabile</surname><given-names>J.</given-names></name><name><surname>Hafler</surname><given-names>K.</given-names></name></person-group><year>2014</year>. <article-title>Determination of six illegal antibiotics
in chicken jerky dog treats</article-title>. <source><italic>J. Agric. Food
Chem.</italic></source><volume>62</volume>: <fpage>3690</fpage>&#x2013;<lpage>3696</lpage>.
doi: <pub-id pub-id-type="doi">10.1021/jf405458m</pub-id><pub-id pub-id-type="pmid">24437928</pub-id></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Thompson</surname><given-names>M. F.</given-names></name><name><surname>Fleeman</surname><given-names>L. M.</given-names></name><name><surname>Kessell</surname><given-names>A. E.</given-names></name><name><surname>Steenhard</surname><given-names>L. A.</given-names></name><name><surname>Foster</surname><given-names>S. F.</given-names></name></person-group><year>2013</year>. <article-title>Acquired proximal renal tubulopathy in
dogs exposed to a common dried chicken treat: retrospective study of 108 cases
(2007&#x2013;2009)</article-title>. <source><italic>Aust. Vet.
J.</italic></source><volume>91</volume>: <fpage>368</fpage>&#x2013;<lpage>373</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/avj.12100</pub-id><pub-id pub-id-type="pmid">23980829</pub-id></mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>T&#xF4;rres</surname><given-names>C. L.</given-names></name><name><surname>Backus</surname><given-names>R. C.</given-names></name><name><surname>Fascetti</surname><given-names>A. J.</given-names></name><name><surname>Rogers</surname><given-names>Q. R.</given-names></name></person-group><year>2003</year>. <article-title>Taurine status in normal dogs fed a
commercial diet associated with taurine deficiency and dilated
cardiomyopathy</article-title>. <source><italic>J. Anim. Physiol. Anim. Nutr.
(Berl.)</italic></source><volume>87</volume>: <fpage>359</fpage>&#x2013;<lpage>372</lpage>.
doi: <pub-id pub-id-type="doi">10.1046/j.1439-0396.2003.00446.x</pub-id><pub-id pub-id-type="pmid">14507418</pub-id></mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Tsai</surname><given-names>M. Y.</given-names></name><name><surname>Marshall</surname><given-names>J. G.</given-names></name><name><surname>Josephson</surname><given-names>M. W.</given-names></name></person-group><year>1980</year>. <article-title>Free amino acid analysis of untimed and
24-h urine samples compared</article-title>. <source><italic>Clin.
Chem.</italic></source><volume>26</volume>: <fpage>1804</fpage>&#x2013;<lpage>1808</lpage>.
<pub-id pub-id-type="pmid">7192188</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
